Approval · Notice of Compliance 25853 · 2021

FOSAVANCE: Notice of Compliance 25853

Issued May 12, 2021

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number: 25853
Date: May 12, 2021
Company: Organon Canada Inc.Kirkland, Quebec, Canada
Product type: Prescription Pharmaceutical
Submission: New Drug Submission (NDS)
Submission class: Admin
Reason: Change in product ownership

Products in this notice

Brand	DIN	Status today
FOSAVANCE	02314940	Marketed
FOSAVANCE	02276429	Marketed

Medicinal ingredients

VITAMIN D3 5,600 UNIT per TAB
ALENDRONIC ACID 70 MG per TAB
VITAMIN D3 2,800 UNIT per TAB